NCT00699426View on ClinicalTrials.gov

The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Type 2 Diabetes

Interventions

DRUG

nexium

40 mg once daily is tested together with Yoghurt

DRUG

nexium

nexium and placebo are tested

DIETARY_SUPPLEMENT

Yoghurt

Yoghurt

DRUG

placebo+placebo

placebo and placebo are tested.

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Novo Nordisk A/S

INDUSTRY

collaborator

Chr Hansen

INDUSTRY

collaborator

Statens Serum Institut

OTHER

collaborator

Steno Diabetes Center Copenhagen

OTHER

lead

Lise Tarnow

OTHER